ID   THTM_HUMAN              Reviewed;         297 AA.
AC   P25325; A8MZ34; B3KP52; J3KPV7; O75750; Q6FHN9;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 160.
DE   RecName: Full=3-mercaptopyruvate sulfurtransferase;
DE            Short=MST;
DE            EC=2.8.1.2;
GN   Name=MPST; Synonyms=TST2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=1953758; DOI=10.1016/S0006-291X(05)81148-9;
RA   Pallini R., Guazzi G.C., Cannella C., Cacace M.G.;
RT   "Cloning and sequence analysis of the human liver rhodanese:
RT   comparison with the bovine and chicken enzymes.";
RL   Biochem. Biophys. Res. Commun. 180:887-893(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Bone marrow, Muscle, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PARTIAL NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 89-112 AND 119-133, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [10]
RP   ASSOCIATION WITH MERCAPTOLACTATE CYSTEINE DISULFIDURIA.
RX   PubMed=4973015;
RA   Ampola M.G., Efron M.L., Bixby E.M., Meshorer E.;
RT   "Mental deficiency and a new aminoaciduria.";
RL   Am. J. Dis. Child. 117:66-70(1969).
RN   [11]
RP   ASSOCIATION WITH MERCAPTOLACTATE CYSTEINE DISULFIDURIA.
RX   PubMed=4690911; DOI=10.1016/0009-8981(73)90480-4;
RA   Niederwiesler A., Giliberti P., Baerlocher K.;
RT   "beta-Mercaptolactate cysteine disulfiduria in two normal sisters.
RT   Isolation and characterization of beta-mercaptolactate cysteine
RT   disulfide.";
RL   Clin. Chim. Acta 43:405-416(1973).
RN   [12]
RP   ASSOCIATION WITH MERCAPTOLACTATE CYSTEINE DISULFIDURIA.
RX   PubMed=6945862; DOI=10.1016/0006-2944(81)90035-1;
RA   Hannestad U., Martensson J., Sjodahl R., Sorbo B.;
RT   "3-mercaptolactate cysteine disulfiduria: biochemical studies on
RT   affected and unaffected members of a family.";
RL   Biochem. Med. 26:106-114(1981).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3 AND SER-35,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15 AND SER-23 (ISOFORM
RP   2), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 11-289.
RG   Structural genomics consortium (SGC);
RT   "Human 3-mercaptopyruvate sulfurtransferase.";
RL   Submitted (SEP-2010) to the PDB data bank.
CC   -!- FUNCTION: Transfer of a sulfur ion to cyanide or to other thiol
CC       compounds. Also has weak rhodanese activity. Detoxifies cyanide
CC       and is required for thiosulfate biosynthesis. Acts as an
CC       antioxidant. In combination with cysteine aminotransferase (CAT),
CC       contributes to the catabolism of cysteine and is an important
CC       producer of hydrogen sulfide in the brain, retina and vascular
CC       endothelial cells. Hydrogen sulfide H(2)S is an important synaptic
CC       modulator, signaling molecule, smooth muscle contractor and
CC       neuroprotectant. Its production by the 3MST/CAT pathway is
CC       regulated by calcium ions (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: 3-mercaptopyruvate + cyanide = pyruvate +
CC       thiocyanate.
CC   -!- ENZYME REGULATION: By oxidative stress, and thioredoxin. Under
CC       oxidative stress conditions, the catalytic cysteine site is
CC       converted to a sulfenate which inhibits the MPST enzyme activity.
CC       Reduced thioredoxin cleaves an intersubunit disulfide bond to turn
CC       on the redox switch and reactivate the enzyme.
CC   -!- SUBUNIT: Monomer; active form. Homodimer; disulfide-linked,
CC       inactive form. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Mitochondrion
CC       {ECO:0000250}. Cell junction, synapse, synaptosome {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P25325-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P25325-2; Sequence=VSP_055027;
CC         Note=Contains a phosphoserine at position 15. Contains a
CC         phosphoserine at position 23. {ECO:0000244|PubMed:18669648,
CC         ECO:0000244|PubMed:24275569};
CC   -!- DOMAIN: Contains two rhodanese domains with different primary
CC       structures but with near identical secondary structure
CC       conformations suggesting a common evolutionary origin. Only the C-
CC       terminal rhodanese domain contains the catalytic cysteine residue
CC       (By similarity). {ECO:0000250}.
CC   -!- DISEASE: Note=Aberrant MPST activity is found in a few cases of
CC       mercaptolactate-cysteine disulfiduria (MCDU) characterized by the
CC       appearance of large quantaties of the sulfur-containing amino
CC       acid, beta-mercaptolactate-cysteine disulfide, in the urine
CC       (PubMed:4973015, PubMed:4690911 and PubMed:6945862). Some cases
CC       have associated mental retardation (PubMed:4973015 and
CC       PubMed:6945862).
CC   -!- MISCELLANEOUS: Thioredoxin (Trx) or dihydrolipoic acid (DHLA) are
CC       required to release hydrogen sulfide from the persulfide
CC       intermediate. {ECO:0000250}.
CC   -!- CAUTION: Was originally thought to be rhodanese.
CC       {ECO:0000305|PubMed:1953758}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH16737.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAG30409.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X59434; CAA42060.1; -; mRNA.
DR   EMBL; BT019636; AAV38442.1; -; mRNA.
DR   EMBL; AK055733; BAG51564.1; -; mRNA.
DR   EMBL; CR541712; CAG46513.1; -; mRNA.
DR   EMBL; Z73420; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW60133.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW60134.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW60135.1; -; Genomic_DNA.
DR   EMBL; BC003508; AAH03508.1; -; mRNA.
DR   EMBL; BC016737; AAH16737.1; ALT_INIT; mRNA.
DR   EMBL; BC018717; AAH18717.1; -; mRNA.
DR   EMBL; CR456523; CAG30409.1; ALT_INIT; mRNA.
DR   CCDS; CCDS13939.1; -. [P25325-1]
DR   CCDS; CCDS46703.1; -. [P25325-2]
DR   PIR; JH0461; ROHU.
DR   RefSeq; NP_001013454.1; NM_001013436.2. [P25325-1]
DR   RefSeq; NP_001123989.1; NM_001130517.2. [P25325-1]
DR   RefSeq; NP_066949.2; NM_021126.5. [P25325-2]
DR   RefSeq; XP_005261667.1; XM_005261610.3. [P25325-1]
DR   UniGene; Hs.248267; -.
DR   PDB; 3OLH; X-ray; 2.50 A; A=11-289.
DR   PDB; 4JGT; X-ray; 2.16 A; A/B/C=11-289.
DR   PDBsum; 3OLH; -.
DR   PDBsum; 4JGT; -.
DR   ProteinModelPortal; P25325; -.
DR   SMR; P25325; -.
DR   BioGrid; 110497; 15.
DR   DIP; DIP-613N; -.
DR   IntAct; P25325; 2.
DR   STRING; 9606.ENSP00000380318; -.
DR   iPTMnet; P25325; -.
DR   PhosphoSitePlus; P25325; -.
DR   SwissPalm; P25325; -.
DR   BioMuta; MPST; -.
DR   DMDM; 6226903; -.
DR   OGP; P25325; -.
DR   REPRODUCTION-2DPAGE; IPI00165360; -.
DR   EPD; P25325; -.
DR   PaxDb; P25325; -.
DR   PeptideAtlas; P25325; -.
DR   PRIDE; P25325; -.
DR   DNASU; 4357; -.
DR   Ensembl; ENST00000341116; ENSP00000342333; ENSG00000128309. [P25325-1]
DR   Ensembl; ENST00000397225; ENSP00000380402; ENSG00000128309. [P25325-1]
DR   Ensembl; ENST00000401419; ENSP00000384812; ENSG00000128309. [P25325-1]
DR   Ensembl; ENST00000404802; ENSP00000383950; ENSG00000128309. [P25325-1]
DR   Ensembl; ENST00000429360; ENSP00000411719; ENSG00000128309. [P25325-2]
DR   GeneID; 4357; -.
DR   KEGG; hsa:4357; -.
DR   UCSC; uc003aql.5; human. [P25325-1]
DR   CTD; 4357; -.
DR   DisGeNET; 4357; -.
DR   GeneCards; MPST; -.
DR   HGNC; HGNC:7223; MPST.
DR   HPA; HPA001240; -.
DR   MIM; 249650; phenotype.
DR   MIM; 602496; gene.
DR   neXtProt; NX_P25325; -.
DR   OpenTargets; ENSG00000128309; -.
DR   PharmGKB; PA30928; -.
DR   eggNOG; KOG1529; Eukaryota.
DR   eggNOG; COG2897; LUCA.
DR   GeneTree; ENSGT00510000046773; -.
DR   HOGENOM; HOG000157237; -.
DR   HOVERGEN; HBG002345; -.
DR   InParanoid; P25325; -.
DR   KO; K01011; -.
DR   OMA; SWGEWGS; -.
DR   OrthoDB; EOG091G0X2Q; -.
DR   PhylomeDB; P25325; -.
DR   TreeFam; TF315133; -.
DR   BioCyc; MetaCyc:HS05177-MONOMER; -.
DR   BRENDA; 2.8.1.2; 2681.
DR   ChiTaRS; MPST; human.
DR   GeneWiki; MPST; -.
DR   GenomeRNAi; 4357; -.
DR   PRO; PR:P25325; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000128309; -.
DR   CleanEx; HS_MPST; -.
DR   ExpressionAtlas; P25325; baseline and differential.
DR   Genevisible; P25325; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-KW.
DR   GO; GO:0016784; F:3-mercaptopyruvate sulfurtransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0004792; F:thiosulfate sulfurtransferase activity; TAS:ProtInc.
DR   GO; GO:0009440; P:cyanate catabolic process; TAS:ProtInc.
DR   GO; GO:0070814; P:hydrogen sulfide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0009636; P:response to toxic substance; TAS:ProtInc.
DR   GO; GO:0021510; P:spinal cord development; IEA:Ensembl.
DR   GO; GO:0019346; P:transsulfuration; IEA:Ensembl.
DR   Gene3D; 3.40.250.10; -; 2.
DR   InterPro; IPR001763; Rhodanese-like_dom.
DR   InterPro; IPR001307; Thiosulphate_STrfase_CS.
DR   Pfam; PF00581; Rhodanese; 2.
DR   SMART; SM00450; RHOD; 2.
DR   SUPFAM; SSF52821; SSF52821; 2.
DR   PROSITE; PS00380; RHODANESE_1; 1.
DR   PROSITE; PS00683; RHODANESE_2; 1.
DR   PROSITE; PS50206; RHODANESE_3; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell junction;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Disulfide bond; Mitochondrion; Phosphoprotein; Redox-active center;
KW   Reference proteome; Repeat; Synapse; Synaptosome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712}.
FT   CHAIN         2    297       3-mercaptopyruvate sulfurtransferase.
FT                                /FTId=PRO_0000139398.
FT   DOMAIN       25    144       Rhodanese 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00173}.
FT   DOMAIN      174    288       Rhodanese 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00173}.
FT   REGION      145    160       Hinge.
FT   ACT_SITE    248    248       Cysteine persulfide intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00173}.
FT   BINDING     188    188       Substrate. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712}.
FT   MOD_RES       3      3       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      35     35       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      40     40       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99J99}.
FT   MOD_RES      40     40       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99J99}.
FT   MOD_RES     146    146       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99J99}.
FT   MOD_RES     164    164       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99J99}.
FT   DISULFID    264    264       Interchain (with C-264); redox-active.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1      1       M -> MAEPGSRESETRARSPSVAAM (in isoform
FT                                2). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055027.
FT   CONFLICT     46     48       RRE -> TQ (in Ref. 1; CAA42060).
FT                                {ECO:0000305}.
FT   CONFLICT    205    205       I -> T (in Ref. 3; BAG51564).
FT                                {ECO:0000305}.
FT   HELIX        13     21       {ECO:0000244|PDB:4JGT}.
FT   STRAND       29     33       {ECO:0000244|PDB:4JGT}.
FT   HELIX        39     41       {ECO:0000244|PDB:4JGT}.
FT   HELIX        45     51       {ECO:0000244|PDB:4JGT}.
FT   TURN         62     64       {ECO:0000244|PDB:4JGT}.
FT   STRAND       71     74       {ECO:0000244|PDB:3OLH}.
FT   HELIX        79     88       {ECO:0000244|PDB:4JGT}.
FT   STRAND       96    100       {ECO:0000244|PDB:4JGT}.
FT   HELIX       110    119       {ECO:0000244|PDB:4JGT}.
FT   STRAND      125    128       {ECO:0000244|PDB:4JGT}.
FT   HELIX       131    137       {ECO:0000244|PDB:4JGT}.
FT   HELIX       160    162       {ECO:0000244|PDB:4JGT}.
FT   HELIX       166    175       {ECO:0000244|PDB:4JGT}.
FT   STRAND      178    182       {ECO:0000244|PDB:4JGT}.
FT   HELIX       186    189       {ECO:0000244|PDB:4JGT}.
FT   HELIX       213    216       {ECO:0000244|PDB:4JGT}.
FT   STRAND      219    221       {ECO:0000244|PDB:3OLH}.
FT   HELIX       226    235       {ECO:0000244|PDB:4JGT}.
FT   STRAND      244    247       {ECO:0000244|PDB:4JGT}.
FT   STRAND      249    252       {ECO:0000244|PDB:4JGT}.
FT   HELIX       255    263       {ECO:0000244|PDB:4JGT}.
FT   STRAND      271    274       {ECO:0000244|PDB:4JGT}.
FT   HELIX       275    283       {ECO:0000244|PDB:4JGT}.
SQ   SEQUENCE   297 AA;  33178 MW;  2313CC15A47A42EA CRC64;
     MASPQLCRAL VSAQWVAEAL RAPRAGQPLQ LLDASWYLPK LGRDARREFE ERHIPGAAFF
     DIDQCSDRTS PYDHMLPGAE HFAEYAGRLG VGAATHVVIY DASDQGLYSA PRVWWMFRAF
     GHHAVSLLDG GLRHWLRQNL PLSSGKSQPA PAEFRAQLDP AFIKTYEDIK ENLESRRFQV
     VDSRATGRFR GTEPEPRDGI EPGHIPGTVN IPFTDFLSQE GLEKSPEEIR HLFQEKKVDL
     SKPLVATCGS GVTACHVALG AYLCGKPDVP IYDGSWVEWY MRARPEDVIS EGRGKTH
//
